FDA product code JXK: Cranial Electrotherapy Stimulator To Treat Depression
JXK is the FDA product code for cranial electrotherapy stimulator to treat depression. It is a Class III device, regulated under 21 CFR 882.5800 and reviewed by the Neurology panel. Devices under JXK reach the market by PMA; FDA lists no cleared 510(k)s for it. 2 PMA applications cite this product code. FDA has posted 3 recalls for JXK devices.
Classification
| Field | Value |
|---|---|
| Device name | Cranial Electrotherapy Stimulator To Treat Depression |
| Device class | Class III |
| Regulation | 21 CFR 882.5800 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | PMA |
Recalls for JXK devices
3 product recalls in 3 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2007-10-29.
Frequently asked questions
What is FDA product code JXK?
JXK is the FDA product code for cranial electrotherapy stimulator to treat depression. It is a Class III device, regulated under 21 CFR 882.5800 and reviewed by the Neurology panel.
What device class is JXK?
Class III, regulation 21 CFR 882.5800. Typical premarket route: PMA.
Have JXK devices been recalled?
Yes: 3 product recalls across 3 recall events; the most recent began 2007-10-29.
Next steps
- Run an FDA pathway report with predicate devices for product code JXK
- Run a recall and safety report across every JXK manufacturer
- Watch product code JXK for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times